Similar companies
Did Cyclerion Therapeutics Beat Earnings?
Cyclerion Therapeutics (CYCN) reported Q4 '24 revenue of $1.8M, with reported EPS of $0.21.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Cyclerion Therapeutics’s job postings, web traffic, and employee business outlook. See the full CYCN stock analysis or the earnings calendar for upcoming reports.
Cyclerion Therapeutics Quarterly Financial Trends
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 190,000 | 1.8M | 81,000 | 93,000 | 880,000 | 1M | — | — |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | — | — |
| Operating margin | -581.4% | 27.8% | -1,798.8% | -1,797.8% | -115.0% | -81.8% | — | — |
| Net income | -720,000 | 530,000 | -1.4M | -320,000 | -980,000 | -800,000 | -3.2M | -1.8M |
| Net margin | -372.7% | 29.3% | -1,764.2% | -348.4% | -111.5% | -78.0% | — | — |
| EPS | — | $0.21 | — | — | — | — | — | — |
Cyclerion Therapeutics Earnings Trend Analysis
Over the eight quarters from Q3 '24 to Q2 '26, Cyclerion Therapeutics’s quarterly revenue moved from $190,000 to $0.
When Is Cyclerion Therapeutics’s Next Earnings Date?
Cyclerion Therapeutics reports earnings on a quarterly schedule. Its most recent report covered Q4 '24. For the confirmed upcoming date — and every other company reporting soon — see the CYCN earnings calendar.
Frequently Asked Questions: Cyclerion Therapeutics Earnings
Cyclerion Therapeutics's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
Cyclerion Therapeutics reported Q4 '24 EPS of $0.21 on revenue of $1.8M. Cyclerion Therapeutics reported EPS of $0.21.
Cyclerion Therapeutics reported Q4 '24 revenue of $1.8M.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the CYCN AI Score.
